Breakthrough in Cancer Diagnosis and Therapy: Cancers Seen Through the Eyes of the Egg
Professor John Herr, Department of Cell Biology
TODAY (3/2/15) at 5pm
Dr. John Herr leads a team in the Medical School that is fusing knowledge from the fields of reproductive biology and cancer biology to redefine the future of cancer diagnosis and therapy. The seminar will review key discoveries underlying U.Va.’s leading role in opening the exciting field of cancer-oocyte neoantigens, chart the diagnostic and therapeutic innovations under development, and discuss the new Charlottesville company Neoantigenics that is developing new cancer therapies and companion diagnostics. Join us to learn about how precision, personalized cancer medicine may be delivered in the future. Anyone and everyone interested in cancer research is welcome and encouraged to attend. Food will be provided. Sign up here.
